Progress and opportunities for immune therapeutics in osteosarcoma.

about

Combination therapy with L-arginine and α-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice.CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.

P2860

Q40398428-29973DFC-E2CA-4FC6-8621-50E12D2EB879 Q55395648-7E8C82FB-2B4E-49BF-A7FF-B9A3D917DE30

P2860

Progress and opportunities for immune therapeutics in osteosarcoma.

Item

http://www.wikidata.org/entity/Q38948905

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Progress and opportunities for immune therapeutics in osteosarcoma.

@en

type

Item

label

Progress and opportunities for immune therapeutics in osteosarcoma.

@en

prefLabel

Progress and opportunities for immune therapeutics in osteosarcoma.

@en

P1476

Progress and opportunities for immune therapeutics in osteosarcoma.

@en

P2093

Christina K Lettieri

http://www.w3.org/2001/XMLSchema#string

Danielle M Lussier

http://www.w3.org/2001/XMLSchema#string

Joseph N Blattman

http://www.w3.org/2001/XMLSchema#string

Nicole Appel

http://www.w3.org/2001/XMLSchema#string

Nicole Labban

http://www.w3.org/2001/XMLSchema#string

Pooja Hingorani

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Cancer immunotherapy: moving beyond current vaccines

New viruses for cancer therapy: meeting clinical needs

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma

CAR T cells for solid tumors: armed and ready to go?

Bispecific T-cell engagers for cancer immunotherapy.

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

P304

1233-1244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2016-0048

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27605071

http://www.w3.org/2001/XMLSchema#string

Progress and opportunities for immune therapeutics in osteosarcoma.

about

P2860

P2860

Progress and opportunities for immune therapeutics in osteosarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698